TS Financial Group (TSFG)’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48K Buy
992
+92
+10% +$3.95K 0.01% 379
2026
Q1
$33K Sell
900
-600
-40% -$28.4K 0.01% 402
2025
Q4
$76K Buy
1,500
+599
+66% +$30.6K 0.01% 283
2025
Q3
$50K Hold
901
0.01% 339
2025
Q2
$62K Buy
901
+250
+38% +$17K 0.01% 302
2025
Q1
$45K Buy
651
+7
+1% +$578 0.01% 330
2024
Q4
$55K Hold
644
0.01% 278
2024
Q3
$77K Sell
644
-6
-0.9% -$800 0.02% 244
2024
Q2
$93K Hold
650
0.02% 207
2024
Q1
$83K Hold
650
0.02% 213
2023
Q4
$67K Buy
650
+200
+44% +$19.8K 0.02% 252
2023
Q3
$41K Hold
450
0.01% 313
2023
Q2
$36K Hold
450
0.01% 329
2023
Q1
$36K Hold
450
0.01% 320
2022
Q4
$30K Buy
+450
New +$26.4K 0.01% 354
2021
Q1
Sell
-76
Closed -$3K 856
2020
Q4
$3K Sell
76
-16
-17% -$553 ﹤0.01% 681
2020
Q3
$3K Hold
92
﹤0.01% 607
2020
Q2
$3K Sell
92
-104
-53% -$3.32K ﹤0.01% 593
2020
Q1
$6K Sell
196
-52
-21% -$1.55K 0.01% 457
2019
Q4
$7K Hold
248
0.01% 478
2019
Q3
$6K Hold
248
﹤0.01% 493
2019
Q2
$6K Hold
248
﹤0.01% 473
2019
Q1
$6K Buy
+248
New +$6.09K 0.01% 455

Other funds holding NVO

TS Financial Group (TSFG)'s NVO Position: Q2 2026 in Review

TS Financial Group (TSFG) increased its Novo Nordisk (NVO) stake by 10% in Q2 2026, buying an estimated $3.95K and bringing the position to 992 shares worth $48K. The position accounts for 0.01% of the portfolio, ranked #379.

TS Financial Group (TSFG) first reported a position in NVO in Q1 2019 and has held it in 23 quarters since. The position peaked at $93K in Q2 2024. 516 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • TS Financial Group (TSFG) held 992 shares of Novo Nordisk worth $48K as of Q2 2026.
  • TS Financial Group (TSFG) bought 92 Novo Nordisk shares in Q2 2026, an estimated $3.95K.
  • Novo Nordisk made up 0.01% of TS Financial Group (TSFG)'s portfolio in Q2 2026, its #379 holding.
  • TS Financial Group (TSFG) first reported a position in Novo Nordisk in Q1 2019 and has held it in 23 quarters since.
  • TS Financial Group (TSFG)'s Novo Nordisk position peaked at $93K in Q2 2024.
  • 516 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on TS Financial Group (TSFG)'s 13F filing for Q2 2026, filed 23 Jul 2026.